Bladder Cancer

Latest News

scientist working in laboratory | Image Credit: © toeytoey - stock.adobe.com
Emulating target trials using observational evidence to inform clinical decision-making

June 2nd 2023

"The emulation framework lends the design and conduct of observational analyses some of the rigor required for the planning of a randomized trial. In doing so, it provides an innovative and principled approach to improve the evidence base on the comparative effectiveness of interventions," writes Boris Gershman, MD, and Aaron Fleishman, MPH.

medical depiction of an x-ray of a human pelvis
Antegrade instillation of UGN-101 for UTUC shows improved safety, similar efficacy, over retrograde

June 1st 2023

BCAN announces 5 recipients of its 2023 Young Investigator Awards
BCAN announces 5 recipients of its 2023 Young Investigator Awards

May 31st 2023

medical depiction of an x-ray of a human bladder
Study identifies patients with NMIBC who are unlikely to respond to BCG therapy

May 30th 2023

Dr. Vilaseca highlights study of erdafitinib intravesical delivery system in bladder cancer
Dr. Vilaseca highlights study of erdafitinib intravesical delivery system in bladder cancer

May 26th 2023

Latest CME Events & Activities

Expert Perspectives on Emerging CDK4/6 Inhibitor Strategies in Advanced Prostate Cancer Management Settings

View More

Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy

View More

Medical Crossfire®: Why is PSMA so Effective? To Affinity and Beyond

View More

Clinical Vignettes: 40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®

View More

Oncology Town Hall™: Primary Investigators Present Key Abstracts in Genitourinary Malignancies from Paris

View More

Show Me Your Care Plan! Developing Multidisciplinary Strategies to Optimize the First-Line Care of Patients with mRCC

View More

Medical Crossfire®: Key Questions on Sequencing, Radioligands, and Novel Emerging Approaches in CRPC

View More

How Guidelines and Recent Clinical Trial Data Inform the Modern-Day Treatment of Advanced Prostate Cancer

View More

Expert Illustrations & Commentaries™: The Role of B7-H3 Across Tumor Types and How It Could Impact Your Practice in the Future

View More

How Guidelines and Recent Clinical Trial Data Inform the Modern-Day Treatment of Advanced Prostate Cancer

View More

How the Experts Treat NMIBC During a BCG Shortage—Integrating Recent Approvals and Investigational Therapies

View More

Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy

View More

Expert Perspectives on Emerging CDK4/6 Inhibitor Strategies in Advanced Prostate Cancer Management Settings

View More

Oncology Town Hall™: Primary Investigators Present Key Abstracts in Genitourinary Malignancies from Paris

View More

Medical Crossfire®: Key Questions on Sequencing, Radioligands, and Novel Emerging Approaches in CRPC

View More

© 2023 MJH Life Sciences

All rights reserved.